Human Insulin

Clinical Pharmacological Studies in Normal Man

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Endocrinology & Metabolism
Cover of the book Human Insulin by D.R. Owens, Springer Netherlands
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: D.R. Owens ISBN: 9789400941618
Publisher: Springer Netherlands Publication: December 6, 2012
Imprint: Springer Language: English
Author: D.R. Owens
ISBN: 9789400941618
Publisher: Springer Netherlands
Publication: December 6, 2012
Imprint: Springer
Language: English

Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin. Human insulin in quantities sufficiently large for therapy has been made available by two techniques developed in parallel during the late 1970s. These involve either (i) formulation in E. coli bacteria suitably encoded by DNA recombinant methods of the A- and B-chains of human insulin followed by a chain combination reaction ('biosynthetic' human insulin) or (ii) enzymatic conversion (transpeptidation) of porcine insulin brought to react with a threonine ester by porcine trypsin in a mixture of water and organic solvents, yielding human insulin ('semi-synthetic' human insulin). This book includes the first clinical-pharmacological studies of each of the highly purified 'semi-synthetic' human insulin preparations: Actrapid ® HM; Monotard® HM; Protaphane® HM; Actraphane® HM; and Ultratard® HM (Novo Industri A/S, Copenhagen). The preliminary studies established their safety and efficacy relative to their porcine and bovine counterparts emphasising the relevance of species and formulation on the pharmacokinetics and biological responses to insulin. Additional investigations with human insulin demonstrated the influence of insulin concentration, site of administration, the addition of aprotinin to insulin and the mixing of 'short-' and 'intermediate-acting' formulations on insulin 'bioavailability'. Examination of the 'within' and 'between' subject day-to-day variation in absorption and the effect of subcutaneous insulin also demonstrates the dominating influence of insulin responsiveness.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin. Human insulin in quantities sufficiently large for therapy has been made available by two techniques developed in parallel during the late 1970s. These involve either (i) formulation in E. coli bacteria suitably encoded by DNA recombinant methods of the A- and B-chains of human insulin followed by a chain combination reaction ('biosynthetic' human insulin) or (ii) enzymatic conversion (transpeptidation) of porcine insulin brought to react with a threonine ester by porcine trypsin in a mixture of water and organic solvents, yielding human insulin ('semi-synthetic' human insulin). This book includes the first clinical-pharmacological studies of each of the highly purified 'semi-synthetic' human insulin preparations: Actrapid ® HM; Monotard® HM; Protaphane® HM; Actraphane® HM; and Ultratard® HM (Novo Industri A/S, Copenhagen). The preliminary studies established their safety and efficacy relative to their porcine and bovine counterparts emphasising the relevance of species and formulation on the pharmacokinetics and biological responses to insulin. Additional investigations with human insulin demonstrated the influence of insulin concentration, site of administration, the addition of aprotinin to insulin and the mixing of 'short-' and 'intermediate-acting' formulations on insulin 'bioavailability'. Examination of the 'within' and 'between' subject day-to-day variation in absorption and the effect of subcutaneous insulin also demonstrates the dominating influence of insulin responsiveness.

More books from Springer Netherlands

Cover of the book Principles of Rock Deformation by D.R. Owens
Cover of the book The Logic of the Living Present by D.R. Owens
Cover of the book Towards Cultural Psychology of Religion by D.R. Owens
Cover of the book Scientific Progress by D.R. Owens
Cover of the book Computational Geomechanics by D.R. Owens
Cover of the book Efficiency, Sustainability, and Justice to Future Generations by D.R. Owens
Cover of the book Summus Mathematicus et Omnis Humanitatis Pater by D.R. Owens
Cover of the book Adaptive Feed-Forward Control of Low Frequency Interior Noise by D.R. Owens
Cover of the book Organizations and Strategies in Astronomy by D.R. Owens
Cover of the book Biorational Control of Arthropod Pests by D.R. Owens
Cover of the book Radar Principles for the Non-Specialist by D.R. Owens
Cover of the book Climatic Changes on a Yearly to Millennial Basis by D.R. Owens
Cover of the book Remaining Issues in the Decommissioning of Nuclear Powered Vessels by D.R. Owens
Cover of the book The Syntax-Phonology Interface in Focus and Topic Constructions in Italian by D.R. Owens
Cover of the book The Problem of Embodiment by D.R. Owens
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy